1. Introduction {#sec1}
===============

Colon cancer is a common malignancy that affects more than 130,000 people each year, causing about 60,000 deaths \[[@B1], [@B2]\]. Although the overall five-year survival of patients with colon cancer is generally high with proper treatment, the complex unknown pathogenesis limits the further improvement in colon cancer treatment \[[@B3], [@B4]\]. Therefore, there is an urgent need for more insights into the pathogenesis of colon cancer. In recent years, miRNAs\' role in cancer research has received increasing attention. miRNA is an important factor in tumorigenesis and metastasis, and its expression characteristics are closely related to the occurrence, progression, and prognosis of various tumors \[[@B5], [@B6]\]. Previous studies have identified some important miRNAs impairing the development of cancers by miRNA expression profiles \[[@B7]--[@B9]\]. Besides, bioinformatics analysis was widely used for the identification of novel biomarkers and mechanism studies \[[@B10], [@B11]\]. In this study, we aimed to search and confirm hub miRNAs that play important parts in the development of colon cancer, thus providing more information for the mechanism research and clinical application of colon cancer.

2. Materials and Methods {#sec2}
========================

2.1. Data Collection and Processing {#sec2.1}
-----------------------------------

The brief workflow of this study is shown in [Figure 1](#fig1){ref-type="fig"}. The microRNA expression profiles of GSE98406, GSE83924, GSE48267, and GSE35834 were downloaded from the Gene Expression Omnibus (GEO) database (<https://www.ncbi.nlm.nih.gov/geo/>). Quantile normalization was performed to normalize all datasets. [](#supplementary-material-1){ref-type="supplementary-material"} lists the details of these datasets. GSE98406 was used as a training dataset for screening DE-microRNAs. GSE83924 and GSE48267 were used as independent sample *T* test sets for verification, respectively. In addition, the clinicopathological correlation analysis for the colon cancer samples in GSE35834 was performed.

2.2. Screening of DE-miRNAs in Colon Cancer Tissues {#sec2.2}
---------------------------------------------------

In this study, the "limma" package in R \[[@B12]\] was used to screen DE-miRNAs between normal colon tissues and tumor tissues. The cutoff criteria were FDR \< 0.05 and \|Log~2~FC\| \> 1.5.

2.3. Functional Enrichment Analysis of Putative Target Genes {#sec2.3}
------------------------------------------------------------

In order to get more knowledge about the candidate miRNAs function, we submitted the selected miRNAs to GCBI to screen their target genes. GCBI is an online tool, which can be used to predict miRNA target genes based on miRanda and TargetScan. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis for target genes were performed. The cut-off criterion is FDR \< 0.05. Also, we drew an interactive network by pathway network (path-net) analysis in GCBI, which covered the significant KEGG pathway to find the hub pathways. The degrees of each pathway in this path-net were calculated, and the top 5 pathways with highest degrees were selected as hub pathways.

2.4. Identification and Validation of HUB miRNAs {#sec2.4}
------------------------------------------------

After understanding the target genes and the GOs for DE-miRNAs, two important networks for this study (miRNA-gene-network and miRNA-GO-network) were built. Based on the ordering of the number of microRNAs in the two networks, we selected the overlapping hub miRNAs and the key regulatory functions of these miRNA. Two datasets (GSE83924 and GSE48267) were used to verify differential expression levels of these miRNAs between normal colon tissues and tumor tissues by independent sample *T* test, respectively. *P* \< 0.05 was considered statistically significant. Meanwhile, the datasets of GSE83924 and GSE48267 were used to perform ROC curve analysis, and the AUC for each hub miRNA was calculated to distinguish the tumor tissues from the normal tissues.

2.5. The Clinical Significance of HUB miRNAs in Colon Cancer {#sec2.5}
------------------------------------------------------------

Based on 52 cases of colon cancer samples with complete clinical information in GSE35834, the relationship between the expression of hub miRNAs and clinicopathological parameters was evaluated by clinicopathological correlation analysis. According to the amount of hub miRNA expression, 52 cases were classified into high expression group and low expression group according to the hub miRNA expression (high group, *n* = 26; low group, *n* = 26). Chi-square tests were used to assess the relationship between the expression of hub miRNA and gender, age, tumor grade, TNM stage, and metastasis of colon cancer patients. A value of *P* \<0.05 was considered as statistically significant.

3. Results {#sec3}
==========

3.1. DE-miRNAs and Target Genes in Colon Tumor Tissues {#sec3.1}
------------------------------------------------------

Under the thresholds of FDR \< 0.05 and \|Log~2~FC\| \> 1.5, a total of 46 DE-miRNAs (14 up-regulated and 32 down-regulated in colon cancer samples) were selected from 7 control samples and 14 colon samples in GSE98406. The volcano plot for DE-miRNAs was taken ([Figure 2](#fig2){ref-type="fig"}) and the characteristics of the dysregulated miRNAs are listed in [Table 1](#tab1){ref-type="table"}. Based on miRanda and TargetScan, 1738 putative miRNA target genes were identified using GCBI ([](#supplementary-material-1){ref-type="supplementary-material"}).

3.2. Functional Enrichment Analysis of Target Genes {#sec3.2}
---------------------------------------------------

To study the roles of DE-miRNAs in mediating colon cancer progression, we performed GO analysis and KEGG pathway enrichment analysis for target genes. The data in [Table 2](#tab2){ref-type="table"} indicate that top 10 GOs were "transcription, DNA-dependent", ''regulation of transcription, DNA-dependent", ''signal transduction", ''positive regulation of transcription from RNA polymerase II promoter", ''apoptotic process", ''positive regulation of transcription, DNA-dependent", ''negative regulation of transcription from RNA polymerase II promoter", ''nervous system development", ''axon guidance" and ''protein phosphorylation". According to the KEGG database, the main pathways involving the target genes were demonstrated. As shown in [Table 3](#tab3){ref-type="table"}, the top 10 pathways were "MAPK signaling pathway", "pathways in cancer", "PI3K-Akt signaling pathway, proteoglycans in cancer", "HTLV-I infection", "endocytosis", "transcriptional mis-regulation in cancer", "neurotrophin signaling pathway", "axon guidance and GnRH signaling pathway". What is more, a pathway network was shown, which covers 25 significantly changed pathways ([Figure 3](#fig3){ref-type="fig"}). Moreover, the MAPK signaling pathway (degrees:41), apoptosis (degrees:27), pathways in cancer (degree:27), cell cycle (degrees:23) and p53 signaling pathway (degrees:23) showed highest connectivity degrees in path-net, which demonstrated these 5 pathways would play a central role in tumor development.

3.3. Hub miRNAs Identification and Validation {#sec3.3}
---------------------------------------------

To identify hub miRNAs and their main functions in the development of colon cancer, we selected target genes and DE-miRNAs to construct miRNAs-gene-networks ([Figure 4](#fig4){ref-type="fig"}) and miRNAs-GO-networks ([Figure 5](#fig5){ref-type="fig"}) according to the significant regulation of GOs and pathways. According to the rank of degrees of miRNAs in two networks, the top rated three miRNAs (miR-17-5p, miR-182-5p, and miR-200a-3p) were determined to be hub miRNAs ([Table 4](#tab4){ref-type="table"}). The bioinformatic analysis showed the hub miRNAs were lowly expressed in colon cancer tissues compared with normal colon tissues. And dysregulated miRNAs play important roles in signal transduction, apoptotic process, and pathways in cancer. GSE83924 and GSE48267 were used to make validation. Further proved by the datasets of GSE83924 and GSE48267, miR-17-5p, miR-182-5p and miR-200a-3p were lowly expressed in tumor tissues ([Figure 6](#fig6){ref-type="fig"}). Besides, ROC curve for GSE83924 indicated that miR-17-5p (AUC = 0.918), miR-182-5p (AUC = 0.853) and miR-200a-3p (AUC = 0.783) exhibited excellent diagnostic efficiency for tumor and normal tissues. And ROC curve for GSE48267 also demonstrated that miR-17-5p (AUC = 0.829), miR-182-5p (AUC = 0.849) and miR-200a-3p (AUC = 0.709) exhibited diagnostic efficiency for tumor and normal tissues ([Figure 7](#fig7){ref-type="fig"}).

3.4. Association of Hub miRNAs Expression with Clinical Significance {#sec3.4}
--------------------------------------------------------------------

Chi-square analysis for GSE35834 showed that miR-17-5p expression was associated with tumor grade significantly (*P* = 0.02), and miR-182-5p expression group was associated with advanced TNM stage (III/IV) (*P* = 0.019). No other significant difference was observed in other clinicopathological features (age, gender, and metastasis) ([](#supplementary-material-1){ref-type="supplementary-material"}).

4. Discussion {#sec4}
=============

In this study, bioinformatics analysis of GSE98406 revealed 46 DE-miRNAs (down-regulated 32 and up-regulated 14). According to the miRNAs-gene-networks and miRNAs-GO-networks, miR-17-5p, miR-182-5p, and miR-200a-3p were considered to be hub miRNAs. They play an important role in tumor development as tumor suppressor genes and oncogenes. Although miR-182-5p and miR-200a-3p have been found to be associated with colorectal cancer \[[@B13]--[@B15]\], there is still a lack of relevant studies exploring its regulatory mechanisms in colon cancer. As for miR-17-5p, it is the first time to discover it was negatively related to tumor progression.

Then, using the target prediction method in the GCBI online tool, 1738 genes were selected as target genes for these DE-miRNAs. The target genes predicted by GO analysis were enriched in "transcription, DNA-dependent", "transcriptional regulation, DNA-dependent", "signal transduction" and "positive regulation of transcription from RNA polymerase II promoter". Interestingly, we noticed the opposite GOs (negative regulation of transcription from RNA polymerase II promoter and Positive regulation of transcription from RNA polymerase II promoter). Taken together, the hub miRNAs (hsa-miR-17-5p, hsa-miR-182-5p and hsa-miR-200a-3p) that we identified were reliable, which may be candidate biomarkers for colon cancer.

As for the 3 hub miRNAs, we conducted a literature review of these miRNAs. miR-17-5p is an important regulator, which has a strong effect on the G1/S phase of cell cycle transition \[[@B16]\]. MiR-17 has been found to target certain genes in some cancers, such as bladder cancer and oral squamous cell carcinoma \[[@B17], [@B18]\]. miR-182-5p is a member of the miR-183/96/182 cluster. Previous studies have identified its important role in breast cancer, glioma, prostate cancer, prostate cancer and renal cell carcinoma \[[@B19]--[@B23]\]. Generally, miR-182-5p regulates the apoptosis of tumor cells by targeting certain special genes, such as FOXO1, MTSS1, HMGA2, CASP9, and FOXO3 \[[@B24], [@B25]\], and these target genes were also predicted by our experiment. miR-200a-3p has been found to play important roles in the epithelial to the mesenchymal transition process in the development of cancer \[[@B26], [@B27]\]. miR-200a-3p plays a role like a tumor suppressor and its target genes are enriched in signal transmission and cell apoptosis control. miR-200a-3p is rarely used as a research focus and related regulatory mechanisms remain to be clarified.

In summary, we identified three hub miRNAs (hsa-miR-17-5p, hsa-miR-182-5p, and hsa-miR-200a-3p), which were closely related to the development of colon cancer. The hub miRNAs we identified might provide references for the functional study of downstream proteins in other study and some clinical targeted treatments in the future. However, due to the small sample size of this study, these results still have certain limitations. Further, in vivo and in vitro studies are needed to understand the exact molecular mechanisms that influence the development of colon cancer.
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Table S2: putative target genes of DE-miRNAs.
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Table S3: clinicopathological correlation analysis for GSE35834.
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Click here for additional data file.

![Flow chart of data preparation, processing, analysis, and validation.](BMRI2020-3981931.001){#fig1}

![The volcano plot for DE-miRNAs.](BMRI2020-3981931.002){#fig2}

![Pathway network (Path-net). Significantly changed pathways were connected in a Path-net to show the interaction network among these pathways. Each pathway in the network was measured by counting the upstream and downstream pathways. The blue circle represents pathways involving upregulated miRNAs, while the yellow circle represents pathways involving both upregulated and downregulated miRNAs. The size of the circle represents the degree value and the lines show the interaction between pathways. A higher degree of pathway indicates that it plays a more important role in the signaling network.](BMRI2020-3981931.003){#fig3}

![miRNAs-gene-network. According to the interactions between miRNAs and the intersected target genes, miRNAs-gene-network was constructed. The blue circles represent genes, while blue square nodes represent downregulated miRNAs. The size of the circle or square node represents the degree value. A higher degree of gene/miRNAs indicates that it plays a more important role in the signaling network.](BMRI2020-3981931.004){#fig4}

![miRNAs-GO-network. The miRNAs-GO-network was generated according to the relationship of significant biological functions and miRNAs. The yellow and blue circles represent GOs, red square nodes represent upregulated miRNAs, and blue square nodes represent downregulated miRNAs. The size of the circle or square node represents the degree value. A higher degree of GO/miRNAs indicates that it plays a more important role in the signaling network.](BMRI2020-3981931.005){#fig5}

![In GSE83924, miRNAs expression levels of miR-17-5p (a), miR-182-5p (b), and miR-200a-3p (c) between normal colon and tumor samples. In GSE48267, miRNAs expression levels of miR-17-5p (d), miR-182-5p (e), and miR-200a-3p (f) between normal colon and tumor samples. Independent sample *T* test was used to evaluate the statistical significance of differences.](BMRI2020-3981931.006){#fig6}

![ROC curve of miR-17-5p, miR-182-5p and miR-200a-3p in the datasets of GSE83924 and GSE48267.](BMRI2020-3981931.007){#fig7}

###### 

The characteristics of the dysregulated miRNAs.

  Rank   miRNAs        FC         FDR        Feature
  ------ ------------- ---------- ---------- ---------
  1      miR-486-5p    5.903792   0.002243   up
  2      miR-451a      3.594096   0.003163   up
  3      miR-378i      2.871432   0.006424   up
  4      miR-126-3p    2.390553   0.007611   up
  5      miR-378a-3p   2.628745   0.008606   up
  6      miR-378c      2.505525   0.009621   up
  7      miR-30a-5p    3.096433   0.011253   up
  8      miR-378f      2.70463    0.012609   up
  9      miR-422a      2.655992   0.013226   up
  10     miR-139-5p    2.804786   0.013957   up
  11     miR-1280      1.776806   0.034109   up
  12     miR-4286      1.997162   0.034955   up
  13     miR-193b-3p   2.347341   0.041491   up
  14     miR-125a-5p   1.83864    0.042671   up
  15     miR-182-5p    −6.34791   0.003257   down
  16     miR-3687      −4.03913   0.004112   down
  17     miR-503-5p    −2.85125   0.004506   down
  18     miR-18b-5p    −3.16775   0.005848   down
  19     miR-4417      −4.53068   0.006188   down
  20     miR-1246      −4.10737   0.00864    down
  21     miR-224-5p    −2.39326   0.008975   down
  22     miR-200c-3p   −3.51686   0.009565   down
  23     miR-552-3p    −2.65361   0.010763   down
  24     miR-877-5p    −2.15946   0.011788   down
  25     miR-501-5p    −1.64608   0.012554   down
  26     miR-203a      −3.40787   0.013864   down
  27     miR-146a-5p   −2.79816   0.015957   down
  28     miR-18a-5p    −2.98152   0.017964   down
  29     miR-210-3p    −2.21905   0.018626   down
  30     miR-424-3p    −2.14658   0.024091   down
  31     miR-1290      −2.70448   0.024521   down
  32     miR-25-5p     −2.3023    0.025739   down
  33     miR-4449      −1.98777   0.026635   down
  34     miR-3651      −2.38984   0.026706   down
  35     miR-141-3p    −2.92073   0.027618   down
  36     miR-17-5p     −1.97557   0.032908   down
  37     miR-200a-3p   −2.79035   0.037529   down
  38     miR-188-5p    −1.81097   0.04154    down
  39     miR-106b-3p   −2.06644   0.042212   down
  40     miR-130b-3p   −1.84017   0.043567   down
  41     miR-21-5p     −2.79495   0.045308   down
  42     miR-19a-3p    −2.02304   0.045882   down
  43     miR-3648      −2.51032   0.045897   down
  44     miR-708-5p    −2.86582   0.046121   down
  45     miR-155-5p    −2.09222   0.048755   down
  46     miR-3175      −2.52047   0.04994    down

###### 

The top 10 dysregulated GOs.

  Rank   GO ID        GO name                                                                Count   FDR
  ------ ------------ ---------------------------------------------------------------------- ------- ----------
  1      GO:0006351   Transcription, DNA-dependent                                           278     1.54E−60
  2      GO:0006355   Regulation of transcription, DNA-dependent                             169     3.34E−27
  3      GO:0007165   Signal transduction                                                    165     1.81E−37
  4      GO:0045944   Positive regulation of transcription from RNA polymerase II promoter   154     5.61E−52
  5      GO:0006915   Apoptotic process                                                      111     4.75E−27
  6      GO:0045893   Positive regulation of transcription, DNA-dependent                    103     1.14E−32
  7      GO:0000122   Negative regulation of transcription from RNA polymerase II promoter   103     2.41E−31
  8      GO:0007399   Nervous system development                                             75      1.70E−30
  9      GO:0007411   Axon guidance                                                          75      4.27E−27
  10     GO:0006468   Protein phosphorylation                                                74      1.61E−24

###### 

The top ten dysregulated pathways of the target genes of DE-miRNAs.

  Rank   Pathway ID   Pathway name                              Count   FDR
  ------ ------------ ----------------------------------------- ------- ----------
  1      04010        MAPK signaling pathway                    69      2.00E−28
  2      05200        Pathways in cancer                        64      8.44E−19
  3      04151        PI3K-Akt signaling pathway                61      1.17E−15
  4      05205        Proteoglycans in cancer                   47      5.80E−15
  5      05166        HTLV-I infection                          47      2.77E−12
  6      04144        Endocytosis                               45      2.58E−15
  7      05202        Transcriptional misregulation in cancer   38      1.97E−12
  8      04722        Neurotrophin signaling pathway            33      3.08E−14
  9      04360        Axon guidance                             31      1.38E−11
  10     04912        GnRH signaling pathway                    24      6.40E−10

###### 

Hub miRNAs in miRNAs-gene-networks and miRNAs-GO-networks.

  Rank   miRNAs        Feature   miRNA-gene-networks degree   miRNA-GO-networks degree
  ------ ------------- --------- ---------------------------- --------------------------
  1      miR-17-5p     down      277                          449
  2      miR-182-5p    down      177                          405
  3      miR-200a-3p   down      126                          342
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